IP Verse

Rna Modulating Oligonucleotides With Improved Characteristics For The Treatment Of Duchenne And Becker Muscular Dystrophy - EP2806900

PATENT ANALYSIS

Patent Details

Grant Date
Dec 15, 2021
Company
BIOMARIN TECHNOLOGIES B.V.
Oppositions

JAMES POOLE LIMITED

STRAWMAN LIMITED

More patents of Biomarin Technologies B.V.

EP3238737

EP2806900

Want to monitor this patent?

Feel free to send us a message here and we will get back to you